Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could One-Time TB pill delivery stop the spread?

NCT ID NCT07628140

First seen Jun 05, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study tests a simpler way to give TB preventive therapy to household contacts of TB patients and people living with HIV. Instead of monthly clinic visits, some participants get the full course of pills at once in their community. Researchers want to see if this approach helps more people finish their treatment and reduces TB transmission.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre for Family Health Research and Development (CEFERD) located at Jaramogi Oginga Odinga Teaching and Referral Hospital

    Kisumu, Kenya

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TB preventive therapy (TPT)

What this could lead to

If successful, this could show that giving TB preventive therapy all at once in the community is a better way to help people finish treatment and reduce TB transmission.

What could go wrong

This trial is not yet recruiting and compares two delivery methods, not a new drug. Results may not apply to other settings or populations.

Conditions

The condition(s) this trial relates to.

latent tuberculosis infection Tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.